Generic Rapamycin ( Sirolimus )

Rapamycin

Rapamycin (sirolimus) is an immunosuppressant agent indicated for the prophylaxis of organ rejection in kidney transplant recipients. It is used in combination with cyclosporine and corticosteroids, or with corticosteroids alone after cyclosporine withdrawal in selected patients. Sirolimus works by binding to the intracellular protein FKBP‑12, forming a complex that inhibits the mammalian target of rapamycin (mTOR), a kinase that regulates cell cycle progression. This inhibition blocks T‑lymphocyte activation and proliferation in response to cytokine and growth factor stimulation, thereby suppressing the immune response against the transplanted organ. Sirolimus is not a calcineurin inhibitor and is not associated with nephrotoxicity at usual therapeutic doses.

Usual adult dose: For de novo kidney transplant recipients, a loading dose of 3 mg/m² is given on the first day after transplantation, followed by a maintenance dose of 1 mg once daily. For patients converted from calcineurin inhibitors after transplant, a loading dose of 2 to 3 mg is given, followed by 1 mg once daily, with subsequent dose adjustments based on whole blood trough concentrations. The 1 mg tablet is the standard maintenance strength. Sirolimus must be taken consistently with or without food to minimize variability in absorption; grapefruit juice must be avoided. The tablets should be swallowed whole. Therapeutic drug monitoring is essential; target trough levels are generally 5 to 15 ng/mL depending on the regimen and time post‑transplant. Dose adjustments are made by the transplant team based on trough levels, renal function, and tolerability. If a dose is missed, the patient should take it as soon as remembered unless it is almost time for the next dose; two doses must not be taken at the same time.

Dosage form: Oral tablets: 1 mg (white to off‑white, triangular‑shaped, film‑coated). Also available as 0.5 mg and 2 mg tablets, and as an oral solution (1 mg/mL) for patients unable to take tablets. The 1 mg tablet is commonly used for once‑daily maintenance therapy.

Onset of action: Immunosuppressive activity begins within hours of the first dose because of rapid absorption; peak whole blood concentrations occur approximately 1 to 2 hours after oral administration. However, steady‑state levels and full therapeutic immunosuppression take 5 to 7 days of continuous daily dosing to establish, which is why a loading dose is used in de novo transplantation.

Duration of action: The elimination half‑life of sirolimus is approximately 62 hours, which is much longer than calcineurin inhibitors. Once‑daily dosing maintains immunosuppression throughout a 24‑hour interval. After discontinuation, the drug is cleared slowly over several days to weeks, so trough levels should be checked and the dose adjusted only by the transplant team.

Alcohol recommendation: Alcohol should be avoided or strictly limited during sirolimus therapy. Alcohol may increase the risk of gastrointestinal irritation and hepatic dysfunction, and can interact with immunosuppressants by worsening lipid abnormalities, which are already a known side effect of sirolimus. Patients should discuss any alcohol use with their transplant specialist.

Most common side effects: Hyperlipidemia (hypercholesterolemia and hypertriglyceridemia), thrombocytopenia, leukopenia, anemia, peripheral edema, hypertension, diarrhea, nausea, headache, and arthralgia. Hyperlipidemia is frequent and may require dietary modification or lipid‑lowering therapy; fasting lipids should be monitored at baseline and periodically. Myelosuppression is dose‑dependent and usually reversible; complete blood counts should be checked regularly, especially in the first months. Sirolimus is associated with impaired wound healing and an increased risk of lymphocele and wound dehiscence; therefore, the medication may be withheld before elective surgery. Delayed graft function and renal function should be monitored when sirolimus is combined with cyclosporine, as this combination may increase calcineurin inhibitor nephrotoxicity. Rarely, interstitial lung disease and hepatic artery thrombosis in liver transplant recipients have been reported. Sirolimus is not recommended in liver or lung transplant recipients because of an increased risk of hepatic artery thrombosis and bronchial anastomotic dehiscence, respectively. Live vaccines should be avoided. Women of childbearing potential must use effective contraception during treatment and for 12 weeks after the last dose, as sirolimus may cause fetal harm. Rapamycin is available only by prescription and must be prescribed and monitored by a transplant specialist or healthcare professional experienced in immunosuppressive therapy.

Would you like to try Rapamycin (Sirolimus) without a prescription?

Select doses
Select Package
Rapamycin
1 mg
x
10 pills
$65.99
$ 54.99
$ 5.50 per pill
save:  $0.00
Rapamycin
1 mg
x
20 pills
$122.39
$ 101.99
$ 5.10 per pill
save:  $8.00
Rapamycin
1 mg
x
30 pills
$179.99
$ 149.99
$ 5.00 per pill
save:  $15.00
Rapamycin
1 mg
x
60 pills
$356.39
$ 296.99
$ 4.95 per pill
save:  $33.00
Rapamycin
1 mg
x
90 pills
$518.39
$ 431.99
$ 4.80 per pill
save:  $63.00
Rapamycin
1 mg
x
120 pills
$670.79
$ 558.99
$ 4.66 per pill
save:  $100.80

Buy Generic Rapamycin (Sirolimus) without prescription in Canada

At our pharmacy, you can buy Rapamycin without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.

What is Rapamycin?

Rapamycin is an immunosuppressant and targeted therapy. The active ingredient is sirolimus, a drug that blocks a protein called mTOR, which stands for mechanistic target of rapamycin. This protein is a master switch that controls cell growth, cell division, and the immune response. By turning down mTOR, rapamycin calms the immune system and slows the growth of certain abnormal cells. It is used for two main purposes: preventing rejection after kidney transplantation, and treating a rare lung disease called lymphangioleiomyomatosis, also known as LAM. It is sometimes used off-label for other conditions, but those are the approved indications.

Rapamycin is not a drug you feel working in minutes. After a kidney transplant, it keeps the immune system from attacking the new organ, and the effect is measured by blood levels of the drug and kidney function tests. For LAM, it slows the decline in lung function over months to years. The usual dose is 1 to 2 mg once daily, adjusted according to blood levels. The 1 mg tablet is the standard starting strength and allows precise dose adjustments. It is taken once daily, consistently, at the same time each day. Because it suppresses the immune system, it demands respect: infections come easier, wounds heal slower, and you need regular blood tests for as long as you take it.

Mechanism and Pharmacology

Sirolimus binds to an intracellular protein called FKBP12. The drug-protein complex then inhibits mTOR, specifically the mTORC1 complex. This blocks the signalling pathways that tell T-cells to multiply and activate. Without that signal, the immune system's attack on a transplanted kidney is dampened, and the organ is tolerated. The same mTOR inhibition reduces the abnormal smooth muscle cell growth seen in LAM. It also has anti-proliferative effects on blood vessels, which is why it is used in some drug-eluting stents. The effect on the immune system is profound and dose-dependent.

After oral administration, sirolimus is absorbed slowly and incompletely, with bioavailability around 15 to 20 percent. Food, especially a high-fat meal, can reduce absorption, so it is usually taken consistently either always with food or always without food. Peak plasma levels occur in about 1 to 3 hours. Sirolimus is extensively metabolized in the liver and the intestinal wall by CYP3A4, and it is a substrate for P-glycoprotein. This means many drug interactions. The half-life is very long, about 57 to 63 hours in adults. Because of the long half-life, a loading dose is often used after transplant. Steady-state is reached after about a week. The drug is eliminated mainly in the feces. Dose adjustment is required in liver impairment, but kidney function does not significantly affect clearance. However, sirolimus can worsen kidney function in some patients, especially when combined with other immunosuppressants like cyclosporine.

How to Use Rapamycin

Take Rapamycin once daily at the same time each day. Be consistent about food: always take it with food, or always take it on an empty stomach, whichever your doctor tells you. Swallow the tablet whole with water. Do not crush or chew it. If you miss a dose, take it as soon as you remember, but if it is almost time for the next dose, skip the missed one. Do not double up. The drug has a long half-life, so one missed dose does not immediately undo everything, but consistency is still important.

After a kidney transplant, a loading dose is often given on the first day, usually 6 mg, followed by a maintenance dose of about 2 mg once daily. The exact dose is then adjusted based on blood levels of sirolimus, called trough levels. For LAM, the dose is usually 1 to 2 mg once daily, also adjusted by blood levels. The 1 mg tablet is used to fine-tune the dose. Never change the dose on your own. Regular blood tests are essential to check your sirolimus level, kidney function, liver enzymes, blood counts, and lipid levels. The drug raises cholesterol and triglycerides, so these are monitored and may require medication. Do not stop Rapamycin without talking to your transplant team or specialist. Stopping after a transplant can cause rejection. Stopping for LAM may cause the lung disease to progress.

Side Effects of Rapamycin

The most common and potentially serious side effect is immunosuppression. You will be more vulnerable to infections, including unusual ones. Wash your hands often, avoid sick people, and report any fever, sore throat, or cough promptly. Wound healing is slower, and the drug should be stopped before and after surgery, but only under medical guidance. Mouth ulcers are very common and can be painful. They usually appear as shallow sores on the tongue or cheeks. Good oral hygiene helps, and a special mouthwash can reduce the discomfort.

Hyperlipidemia is expected. Sirolimus raises cholesterol and triglycerides in most patients. A statin or other lipid-lowering drug is often prescribed alongside. Thrombocytopenia, low platelets, can occur, and your blood counts will be monitored. Anemia is also possible. Protein in the urine and reduced kidney function can happen, especially when combined with calcineurin inhibitors like cyclosporine or tacrolimus. Your urine protein and serum creatinine are checked regularly. Delayed wound healing and fluid retention are common in the transplant setting. Interstitial pneumonitis, inflammation of the lungs, is a rare but serious complication. Symptoms include cough, shortness of breath, and fever. If these appear, stop the drug and call your doctor. Liver enzyme elevations can occur but are usually mild.

High-Risk Groups (Elderly, Pregnancy)

Pregnancy. Sirolimus is pregnancy category C. Animal studies have shown fetal harm at high doses. It should not be used during pregnancy unless the benefit clearly outweighs the risk. Women of childbearing age should use effective contraception during treatment and for at least 12 weeks after the last dose. If pregnancy occurs, the patient must be informed of the risk. Breastfeeding is not recommended while taking sirolimus, as the drug may pass into breast milk.

Elderly patients can use sirolimus, but they are more likely to have reduced liver function, high cholesterol, and impaired wound healing. Doses are often lower, and monitoring is more frequent. Patients with moderate to severe liver impairment require a reduced dose because the drug is cleared by the liver. Kidney function does not require a dose change, but the drug can worsen proteinuria and renal function, so these are watched closely. Patients with a history of infections, including hepatitis B or C, should be monitored because the drug can reactivate latent infections. Those with a history of high cholesterol or triglycerides need lipid-lowering therapy before or soon after starting. People planning surgery must tell their surgeon they are on sirolimus, as the drug impairs wound healing and increases the risk of infection. It may need to be held before elective procedures.

Interaction With Activities (Driving, Alcohol)

Rapamycin can cause fatigue, dizziness, and headache. If you feel tired or lightheaded, don't drive. These effects are usually mild and improve over time. Alcohol should be limited or avoided. Alcohol can worsen liver irritation, raise triglycerides, and add to the fatigue. It can also increase the risk of stomach irritation when combined with other medications. Heavy drinking is strongly discouraged. If you drink, keep it light and tell your doctor honestly. Grapefruit and grapefruit juice must be avoided entirely. They inhibit CYP3A4 and can cause dangerous spikes in sirolimus blood levels.

Drug Interactions

Sirolimus is metabolized by CYP3A4 and is a substrate for P-glycoprotein. The list of interactions is long. Strong CYP3A4 inhibitors, like ketoconazole, itraconazole, clarithromycin, and ritonavir, can dramatically increase sirolimus levels, leading to toxicity. Strong CYP3A4 inducers, like rifampin, phenytoin, carbamazepine, and St. John's Wort, can lower sirolimus levels and reduce its effectiveness, risking transplant rejection. These combinations require careful dose adjustment and frequent blood level monitoring. Grapefruit and grapefruit juice are absolutely forbidden.

Cyclosporine and tacrolimus, two other immunosuppressants, interact significantly with sirolimus. When given with cyclosporine, sirolimus levels are increased, and the combination increases the risk of kidney damage. The two drugs should be separated by at least 4 hours. Tacrolimus levels may also change. Live vaccines should not be given during treatment because of the immunosuppressive effect. Inactivated vaccines may be given but may be less effective. Antibiotics and antifungals that affect CYP3A4 must be reviewed. Warfarin and other anticoagulants may interact, and INR should be monitored. Always tell your doctor and pharmacist about every medication, supplement, and herbal product you take before starting Rapamycin.

Alternative Options

For kidney transplant immunosuppression, the standard alternatives are tacrolimus (Prograf), cyclosporine (Neoral), and mycophenolate mofetil (CellCept). Tacrolimus is the most commonly used calcineurin inhibitor because it has a lower risk of rejection and a slightly better side effect profile. Sirolimus is often reserved for patients who cannot tolerate calcineurin inhibitors, or who have certain cancers after transplant, because it has anti-tumour properties. For LAM, sirolimus is the only proven medical therapy. No alternative has shown the same benefit in slowing lung function decline. For other mTOR-related conditions, everolimus (Afinitor) is sometimes used, but it is not interchangeable with sirolimus in transplant protocols. The choice of immunosuppressant depends on the organ transplanted, the patient's immune risk, and side effect tolerance.

INN, Brand Names, and Classification in Canada

INN (International Nonproprietary Name): Sirolimus
Available brand names in Canada: Rapamune, and generic sirolimus. Rapamycin is the original name for sirolimus and is used interchangeably.
ATC code: L04AA10
Forms and strengths: Tablets 1 mg and 2 mg; oral solution 1 mg/mL. The 1 mg tablet is the standard starting strength for dose adjustment.
Manufacturers: Pfizer Canada Inc. (Rapamune), and diverse generic manufacturers including Apotex Inc. and Teva Canada Limited.
Registration status in Canada: Registered
Classification: Prescription (Rx)

Frequently Asked Questions

Why must I have regular blood tests?
Sirolimus has a narrow therapeutic window. Too little, and you risk transplant rejection or loss of effect. Too much, and you risk toxicity, including kidney damage, high cholesterol, and infection. Blood tests measure the drug level, your kidney function, your liver enzymes, your blood counts, and your lipids. These results guide every dose adjustment.

Can I take Rapamycin with food?
Yes, but you must be consistent. Taking it always with food or always without food keeps the absorption predictable. A high-fat meal can reduce absorption, so choose one routine and stick to it. Grapefruit is always forbidden.

Will I get mouth ulcers?
Mouth ulcers are one of the most common side effects. They can be painful but are usually manageable. Good oral hygiene and avoiding spicy, acidic, or hard foods help. If they are severe, your doctor may adjust the dose or prescribe a mouthwash. They heal when the dose is reduced or the drug is stopped.

What should I do if I develop a fever?
Because your immune system is suppressed, a fever can be the first sign of a serious infection. Contact your transplant team or doctor immediately. Do not wait. You may need urgent evaluation and antibiotics.

Can I stop taking Rapamycin once my kidney is stable?
No. Immunosuppression after a transplant is lifelong. Stopping sirolimus can cause acute rejection and loss of the kidney. If you have concerns about side effects, talk to your transplant team before making any changes.

Delivery Information Across Canada

We ship Rapamycin and generic sirolimus to all provinces and territories. Delivery times vary depending on how remote your location is:

  • Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
  • Quebec (Montreal, Quebec City, Laval): 5 to 7 days
  • British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
  • Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
  • Manitoba (Winnipeg, Brandon): 5 to 9 days
  • Saskatchewan (Saskatoon, Regina): 5 to 9 days
  • Nova Scotia (Halifax, Sydney): 5 to 9 days
  • New Brunswick (Moncton, Fredericton): 5 to 9 days
  • Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
  • Prince Edward Island (Charlottetown): 7 to 14 days
  • Yukon, Northwest Territories, Nunavut: 7 to 14 days

All shipments are packed discreetly with no branding or indication of contents on the outside.

There is no review for this product at the moment, but you can be the first to add or you can read more in Testimonials Page about related products.
Package Example
Front View
Side View
Back View
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Shipping method Delivery time Price  
Delivery 14-21 days 14.95$ Tracking# available in 4 days
Delivery 9-14 days 30$ Tracking# available in 2 days
  • Shipping worldwide
  • Confidentiality and anonymity guarantee
  • Safe and secure
  • Discrete looking packages
  • Dispatch orders within 24 hours
  • 100% success delivery